T1 mapping and T2 mapping at 3T for quantifying the area-at-risk in reperfused STEMI patients.
Bulluck H, White SK, Rosmini S, Bhuva A, Treibel TA, Fontana M, Abdel-Gadir A, Herrey A, Manisty C, Wan SM, Groves A, Menezes L, Moon JC, Hausenloy DJ.
Bulluck H, et al. Among authors: fontana m.
J Cardiovasc Magn Reson. 2015 Aug 12;17(1):73. doi: 10.1186/s12968-015-0173-6.
J Cardiovasc Magn Reson. 2015.
PMID: 26264813
Free PMC article.